Insider · CIK 0001666790

Bonner Michael

Reports to the SEC for 1 company · NASHVILLE, TN

sec.gov

Transactions

Companies

Filings

CIK

0001666790

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-17	CPIXCUMBERLAND PHARMACEUTICALS INC · Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2021-05-17	CPIXCUMBERLAND PHARMACEUTICALS INCJ Other	Chief Financial Officer	JOther	−7,500 sh	$2.83	−$21.2K	11,720
2021-03-17	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−1,067 sh	$3.22	−$3,435.74	19,220
2021-03-17	CPIXCUMBERLAND PHARMACEUTICALS INC · Options (right to buy)A Award	Chief Financial Officer	AAward	+5,000 sh	—	—	5,000
2020-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+2,500 sh	$3.56	+$8,900	20,287
2020-03-18	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−2,134 sh	$3.53	−$7,533.02	17,787
2019-03-22	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	+1,033 sh	$5.62	+$5,805.46	19,921
2019-03-22	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+2,500 sh	$5.98	+$15K	20,954
2018-08-29	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+100 sh	$6.24	+$624	18,454
2018-08-28	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+300 sh	$5.92	+$1,776	18,354
2018-05-17	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+400 sh	$6.12	+$2,448	18,054
2018-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+2,500 sh	$6.70	+$16.8K	18,497
2018-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−843 sh	$6.70	−$5,648.1	17,654
2018-03-19	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+300 sh	$6.72	+$2,016	15,997
2017-11-22	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+250 sh	$7.81	+$1,952.5	15,697
2017-08-23	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+500 sh	$6.72	+$3,360	15,447
2017-05-31	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+300 sh	$6.95	+$2,085	14,947
2017-04-07	CPIXCUMBERLAND PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−653 sh	$6.45	−$4,211.85	14,647
2017-04-07	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+2,500 sh	$6.45	+$16.1K	15,300
2017-03-23	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+900 sh	$6.42	+$5,778	12,800
2016-11-17	CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase	Chief Financial Officer	PPurchase	+900 sh	$5.50	+$4,950	11,900
2016-04-06	CPIXCUMBERLAND PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+5,000 sh	$4.34	+$21.7K	11,000

Recent filings

Accepted (ET)
Jun 114
Bonner Michael0001209191-21-039917
SEC(opens sec.gov)
Apr 174
Bonner Michael0001209191-20-024880
SEC(opens sec.gov)
Mar 224
Bonner Michael0001209191-19-021052
SEC(opens sec.gov)
Aug 314
Bonner Michael0001209191-18-049112
SEC(opens sec.gov)
May 184
Bonner Michael0001209191-18-031475
SEC(opens sec.gov)
Mar 234
Bonner Michael0001209191-18-021463
SEC(opens sec.gov)
Nov 244
Bonner Michael0001209191-17-062464
SEC(opens sec.gov)
Aug 254
Bonner Michael0001209191-17-050310
SEC(opens sec.gov)
Jun 24
CUMBERLAND PHARMACEUTICALS INC0001209191-17-037364
SEC(opens sec.gov)
Apr 74
CUMBERLAND PHARMACEUTICALS INC0001209191-17-026295
SEC(opens sec.gov)
Mar 244
CUMBERLAND PHARMACEUTICALS INC0001209191-17-022787
SEC(opens sec.gov)

Companies

CUMBERLAND PHARMACEUTICALS INCChief Financial OfficerCPIX

Address

2525 WEST END AVENUE, SUITE 950

NASHVILLE, TN, 37203